Skip to main content
. 2023 May 19;17:54–57. doi: 10.33393/dti.2023.2573

TABLE I -.

Baseline characteristics and CCB treatment of patients with hypertension categorized by lung cancer (case group) and tuberculosis (control group)

Factors Cases (n = 69) Controls (n = 109) p value
Data presented as number (percentage) except * indicated as median (1st-3rd quartile range).
BMI = body mass index; CCB = calcium channel blocker; CKD = chronic kidney disease; CVD = cardiovascular disease; DM = diabetic mellitus; HBV = hepatitis B virus; HCV = hepatitis C virus; NA = not available; OSA = obstructive sleep apnea.
Age, years* 67 (61,71) 66 (59,71) 0.603
Male 44 (63.8) 77 (70.6) 0.338
Female 25 (36.2) 32 (29.4)
BMI     0.676
 <19 13 (18.8) 17 (15.9)  
 19-24.5 16 (23.2) 25 (23.4)  
 24.5-30 5 (7.2) 4 (3.7)  
 >30 35 (50.7) 61 (57.0)  
Smoking 40 (58) 64 (58.7) 0.922
Alcohol drinking 28 (40.6) 53 (48.6) 0.294
Comorbidities      
 CVD 10 (14.5) 17(15.6) 0.841
 Dyslipidemia 29 (42) 27 (24.8) 0.016
 DM 27 (39.1) 48 (44) 0.518
 OSA 5 (7.2) 1 (0.9) 0.033
 CKD 10 (14.5) 23 (21.1) 0.269
 Ischemic stroke 6 (8.7) 2 (1.8) 0.057
 Autoimmune 2 (2.9) 4 (3.7) >0.999
 HBV infection 2 (2.9) 3 (2.8) >0.999
 HCV infection 0 5 (4.6) 0.158
 Hyperthyroidism 1 (1.4) 0 0.388
Family history of lung cancer 11 (15.9) 1 (0.9) <0.001
Occupational exposure 1 (1.4) 2 (1.8) >0.999
Chest wall radiation 0 0 NA
CCB used 45 (65.2) 62 (56.9) 0.268
CCB duration, years* 5 (3-10) 6 (2.8-8.2) 0.642